Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 7,040.00
-170.00 (-2.36%)
At close: Sep 3, 2026
Biodyne Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Cash & Equivalents | 11,753 | 12,981 | 4,833 |
Short-Term Investments | 3,000 | 3,000 | 15,880 |
Cash & Short-Term Investments | 14,753 | 15,981 | 20,713 |
Cash Growth | - | -22.85% | - |
Accounts Receivable | 1,720 | 1,657 | 716.61 |
Other Receivables | 399.41 | 436.76 | 335.04 |
Receivables | 2,119 | 2,094 | 1,052 |
Inventory | 508.43 | 460.6 | 436.78 |
Prepaid Expenses | 8.77 | 0.14 | - |
Other Current Assets | 25.74 | 165.38 | 159.12 |
Total Current Assets | 17,416 | 18,700 | 22,361 |
Property, Plant & Equipment | 14,283 | 13,392 | 10,836 |
Long-Term Investments | 7,854 | 7,715 | 7,361 |
Other Intangible Assets | 4,266 | 4,669 | 3,346 |
Long-Term Deferred Tax Assets | 562.55 | 463.83 | 443.65 |
Other Long-Term Assets | - | 0 | 0 |
Total Assets | 44,382 | 44,940 | 44,347 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Accounts Payable | 28.81 | 386.62 | 60.51 |
Accrued Expenses | 112.29 | 137.53 | 257.05 |
Current Portion of Leases | 6.33 | 11.04 | 12.07 |
Other Current Liabilities | 231.62 | 335.49 | 818.05 |
Total Current Liabilities | 379.04 | 870.68 | 1,148 |
Total Liabilities | 379.04 | 870.68 | 1,148 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Common Stock | 14,882 | 14,882 | 14,882 |
Additional Paid-In Capital | 34,294 | 54,294 | 54,294 |
Retained Earnings | 5,225 | -14,608 | -15,459 |
Treasury Stock | -10,517 | -10,517 | -10,517 |
Comprehensive Income & Other | 119.05 | 18.06 | 0 |
Shareholders' Equity | 44,003 | 44,069 | 43,200 |
Total Liabilities & Equity | 44,382 | 44,940 | 44,347 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Total Debt | 6.33 | 11.04 | 12.07 |
Net Cash (Debt) | 14,747 | 15,970 | 20,701 |
Net Cash Growth | - | -22.86% | - |
Net Cash Per Share | 517.80 | 541.77 | 702.30 |
Filing Date Shares Outstanding | 29.37 | 29.48 | 29.48 |
Total Common Shares Outstanding | 29.37 | 29.48 | 29.48 |
Working Capital | 17,037 | 17,830 | 21,213 |
Book Value Per Share | 1498.36 | 1495.05 | 1465.55 |
Tangible Book Value | 39,737 | 39,400 | 39,854 |
Tangible Book Value Per Share | 1353.09 | 1336.65 | 1352.03 |
Land | 6,796 | 6,796 | 6,796 |
Buildings | 1,999 | 1,999 | 1,999 |
Machinery | 3,380 | 2,651 | 2,716 |
Construction In Progress | 1,872 | 1,497 | 1,371 |